Indeed, previous studies indicate that both TERT promoter mutations and TERT mRNA expression indicate worse clinical outcome in differentiated thyroid carcinoma and may also be associated to higher Ki-67 indices [29, 34–36]. The gene discussed is TERT; the disease is differentiated thyroid carcinoma.